Sezioni/Pharma IT

Pharma IT

Dove l'integrità dei dati, l'automazione e l'IA incontrano davvero il piano di produzione.

Integrità dei datiAutomazioneIACSA
AI Governance In Pharma: Is It Becoming The New GMP?Articolo
Storia di apertura

AI Governance In Pharma: Is It Becoming The New GMP?

GMP built trust in physical manufacturing. Now algorithms need the same guardrails, here's why AI governance is following its playbook.

Simantini Singh Deo · 29 lug 2026
Rethinking Life Sciences Quality & Manufacturing Operations in the Age of AI & Connected Systems
Articolo

Rethinking Life Sciences Quality & Manufacturing Operations in the Age of AI & Connected Systems

Discover how AI and connected systems enable real-time quality management in modern life sciences manufacturing.

Team Pharma Now · 15 set 2026
Safety Data Was Never a Cost. AI Just Proved It.
Articolo

Safety Data Was Never a Cost. AI Just Proved It.

AI in Pharmacovigilance is unlocking value long buried in safety data, from drug repurposing to faster regulatory submissions.

Ashish Dwivedi · 9 set 2026
Building the Knowledge Foundations for AI-Ready Pharmaceutical Quality Systems
Articolo

Building the Knowledge Foundations for AI-Ready Pharmaceutical Quality Systems

How pharmaceutical quality systems can build the knowledge foundations needed for trustworthy AI across CMC and CGMP.

Dr. Ajaz Hussain · 3 set 2026
5 Considerations for Building a More Connected Digital QA/QC Laboratory
Articolo

5 Considerations for Building a More Connected Digital QA/QC Laboratory

Explore five key considerations for building a connected digital QA/QC laboratory, with practical insights on data integrity, integration, standardization, and AI readiness.

Vamsi Reddy · 31 ago 2026
Audit Trail Review In Pharma Is The New FDA Finding, Not Existence
Articolo

Audit Trail Review In Pharma Is The New FDA Finding, Not Existence

FDA inspectors now ask who reviewed the audit trail, not just whether one exists, here's what's driving Audit Trail Review In Pharma citations.

Mrudula Kulkarni · 29 ago 2026
Annex 22 Is Not Law Yet. What to Invest in Now
Articolo

Annex 22 Is Not Law Yet. What to Invest in Now

Annex 22 isn't law yet — this piece verifies its real EudraLex status and lays out the 7 investments pharma sites should fund now, regardless of the final date.

Mrudula Kulkarni · 12 ago 2026
Rasayan Labs Emerges as a Unified AI Operating System for Generic Drug Development, Moving Beyond the Limits of Traditional Tools
Articolo

Rasayan Labs Emerges as a Unified AI Operating System for Generic Drug Development, Moving Beyond the Limits of Traditional Tools

Discover how Rasayan Labs is unifying AI-powered generic drug development with a single platform that accelerates API R&D, formulation, regulatory workflows, and more.

Team Pharma Now · 30 lug 2026
Can AI Decode the Gut? : Machine Learning in Microbiome Research
Articolo

Can AI Decode the Gut? : Machine Learning in Microbiome Research

AI is decoding microbial patterns humans can't see. Here's how machine learning is transforming microbiome research into clinical reality.

Dr. Nalini Raghunathan · 1 lug 2026
How ML Virtual Screening Is Scaling Cancer Drug Targets?
Articolo

How ML Virtual Screening Is Scaling Cancer Drug Targets?

ML virtual screening hits 18-45% in prospective trials vs sub-1% for HTS, unlocking undruggable cancer targets.

Mrudula Kulkarni · 30 giu 2026